数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
李志林 Chairman, President, Chief Executive Officer and Interim Chief Financial Officer 70 24.16万美元 1385.82 2023-11-07
张应文 Independent Director 78 0.62万美元 未持股 2023-11-07
徐向媚 Director 66 1.60万美元 93.13 2023-11-07
Gene Michael Bennett Independent Director 76 1.60万美元 未持股 2023-11-07
董宝文 Independent Director 82 0.62万美元 未持股 2023-11-07

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
李志林 Chairman, President, Chief Executive Officer and Interim Chief Financial Officer 70 24.16万美元 1385.82 2023-11-07

董事简历

中英对照 |  中文 |  英文
李志林

李志林是公司的董事长、总裁、首席执行官和临时财务总监。她自2006年起担任董事,2005年任总裁和首席执行官,是惠普森的创立者,1993年至2005年是惠普森的董事长和首席执行官。以前是海口生物工程学院的校长和四川生物学院的副校长,毕业于四川大学,拥有生物学学位。


Zhilin Li,has served as a director since 2006 and as the President and Chief Executive Officer since 2005. She was a founder of Helpson, and served as Chairman and Chief Executive Officer of Helpson from 1993 to 2005. Ms. Li was formerly the president of Haikou Bio-Engineering Institute as well as the vice president of Sichuan Institute of Biology. She graduated from Sichuan University with a degree in biology.
李志林是公司的董事长、总裁、首席执行官和临时财务总监。她自2006年起担任董事,2005年任总裁和首席执行官,是惠普森的创立者,1993年至2005年是惠普森的董事长和首席执行官。以前是海口生物工程学院的校长和四川生物学院的副校长,毕业于四川大学,拥有生物学学位。
Zhilin Li,has served as a director since 2006 and as the President and Chief Executive Officer since 2005. She was a founder of Helpson, and served as Chairman and Chief Executive Officer of Helpson from 1993 to 2005. Ms. Li was formerly the president of Haikou Bio-Engineering Institute as well as the vice president of Sichuan Institute of Biology. She graduated from Sichuan University with a degree in biology.
张应文

张应文,男,汉族,1945年5月出生,大学文化,中共党员,化工工程师,高级经济师,国家注册安全工程师。曾任中国石化集团重庆四川维尼纶厂总厂厂长、四川省对外贸易经济合作委员会主任、中国驻马来西亚大使馆经济商务参赞、中化化肥公司(HK297)高级顾问及重庆万里新能源股份有限公司独立董事,现任上海力声特医学科技有限公司副董事长及重庆万里新能源股份有限公司第七届董事会董事。张应文自2008年2月起担任海南惠普森医药生物技术有限公司独立董事。他目前还担任医疗器械生产商上海瑞特医疗科技有限公司的顾问。2005年10月至2009年6月,任中化集团中化控股有限公司(HKG:0297)HSE健康安全与环境委员会主席及高级顾问。2007年至2018年,他担任上市公司重庆新能源股份有限公司(SH。600847)的独立董事。此外,张先生于2000年3月至2005年10月被任命为中国驻马来西亚大使馆商务参赞。在此之前,张先生于1988年至2000年被任命为四川省对外贸易经济合作局(中国四川省商务局)局长。在他早期的职业生涯中,他是一名化学工程师和高级经济学家,然后成为中国几家化工公司的高级经理。1983年至1988年,张先生担任中国石化集团下属的中国一家大型天然气化工国有企业(SOE)的副首席执行官和首席执行官。张先生1967年毕业于天津大学化工系。


Yingwen Zhang,has served as China Pharma Holdings, Inc. independent director since February 2008. He also currently serves as a consultant of Shanghai Listent Medical Tech Co. Ltd., a medical device producer. He acted as Senior Consultant and Chairman of HSE (Health Safe and Environment) Committee of SINOFERT Holdings Limited (HKG: 0297) of SINOCHEM Group from October 2005 to June 2009. He served as an independent director of a public company, Chongqing New Energy Co., Ltd. (SH.600847), from 2007 to 2018. Additionally, Mr. Zhang was appointed as the Commercial Counselor of the China Embassy in Malaysia from March 2000 through October 2005.Prior to that, from 1988 to 2000, Mr. Zhang was appointed as the Director-General to Sichuan Provincial Foreign Trade and Economic Cooperation Bureau (the Commercial Bureau of Sichuan Province, China). In his early career he was a chemical engineer and senior economist, and then became a senior manager for several chemical corporations in China. From 1983 to 1988, Mr. Zhang served as vice CEO and then CEO of a large nature-gas chemical state-owned enterprise (SOE) in the PRC affiliated with the SINOPEC Group. Mr. Zhang graduated from the Chemical Engineering Department of Tianjin University in 1967.
张应文,男,汉族,1945年5月出生,大学文化,中共党员,化工工程师,高级经济师,国家注册安全工程师。曾任中国石化集团重庆四川维尼纶厂总厂厂长、四川省对外贸易经济合作委员会主任、中国驻马来西亚大使馆经济商务参赞、中化化肥公司(HK297)高级顾问及重庆万里新能源股份有限公司独立董事,现任上海力声特医学科技有限公司副董事长及重庆万里新能源股份有限公司第七届董事会董事。张应文自2008年2月起担任海南惠普森医药生物技术有限公司独立董事。他目前还担任医疗器械生产商上海瑞特医疗科技有限公司的顾问。2005年10月至2009年6月,任中化集团中化控股有限公司(HKG:0297)HSE健康安全与环境委员会主席及高级顾问。2007年至2018年,他担任上市公司重庆新能源股份有限公司(SH。600847)的独立董事。此外,张先生于2000年3月至2005年10月被任命为中国驻马来西亚大使馆商务参赞。在此之前,张先生于1988年至2000年被任命为四川省对外贸易经济合作局(中国四川省商务局)局长。在他早期的职业生涯中,他是一名化学工程师和高级经济学家,然后成为中国几家化工公司的高级经理。1983年至1988年,张先生担任中国石化集团下属的中国一家大型天然气化工国有企业(SOE)的副首席执行官和首席执行官。张先生1967年毕业于天津大学化工系。
Yingwen Zhang,has served as China Pharma Holdings, Inc. independent director since February 2008. He also currently serves as a consultant of Shanghai Listent Medical Tech Co. Ltd., a medical device producer. He acted as Senior Consultant and Chairman of HSE (Health Safe and Environment) Committee of SINOFERT Holdings Limited (HKG: 0297) of SINOCHEM Group from October 2005 to June 2009. He served as an independent director of a public company, Chongqing New Energy Co., Ltd. (SH.600847), from 2007 to 2018. Additionally, Mr. Zhang was appointed as the Commercial Counselor of the China Embassy in Malaysia from March 2000 through October 2005.Prior to that, from 1988 to 2000, Mr. Zhang was appointed as the Director-General to Sichuan Provincial Foreign Trade and Economic Cooperation Bureau (the Commercial Bureau of Sichuan Province, China). In his early career he was a chemical engineer and senior economist, and then became a senior manager for several chemical corporations in China. From 1983 to 1988, Mr. Zhang served as vice CEO and then CEO of a large nature-gas chemical state-owned enterprise (SOE) in the PRC affiliated with the SINOPEC Group. Mr. Zhang graduated from the Chemical Engineering Department of Tianjin University in 1967.
徐向媚

徐向媚,2009年4月28日任公司董事,2005年10月至2008年2月是董事会成员,她是自己创业的女商人,从事战略投资,之前从事制药化工原材料的进出口业务。她在1982年毕业于华南财经大学,在贸易方面的经验赋予了她在制药行业的独到眼光,为公司在战略和规划以及执行领域赢得了效益。


Heung Mei Tsui,has served as a director of the Company since April 28, 2009. Previously, Ms. Tsui served as a member of China Pharma Holdings, Inc. board from October 2005 to February 2008. Ms. Tsui has been a self-employed businesswoman engaged in strategic investments and was previously engaged in the pharmaceutical chemical raw material import/export business. Ms. Tsui graduated from Hunan Financial& Economic College in 1982.
徐向媚,2009年4月28日任公司董事,2005年10月至2008年2月是董事会成员,她是自己创业的女商人,从事战略投资,之前从事制药化工原材料的进出口业务。她在1982年毕业于华南财经大学,在贸易方面的经验赋予了她在制药行业的独到眼光,为公司在战略和规划以及执行领域赢得了效益。
Heung Mei Tsui,has served as a director of the Company since April 28, 2009. Previously, Ms. Tsui served as a member of China Pharma Holdings, Inc. board from October 2005 to February 2008. Ms. Tsui has been a self-employed businesswoman engaged in strategic investments and was previously engaged in the pharmaceutical chemical raw material import/export business. Ms. Tsui graduated from Hunan Financial& Economic College in 1982.
Gene Michael Bennett

Gene Michael Bennett,自2008年2月起担任China Pharma Holdings, Inc.的独立董事。目前,Bennett先生是Omana Healthcare, Ltd (Mission Viejo, California, USA)的董事会主席和合伙人,以及Prescient Crossborder Business Consulting, Ltd (Shenzhen, PRC)的董事长和合伙人。从2013年到2015年,Bennett先生担任Kang Jia Fu, Royal Traditional Health Investment Management Co. Ltd(位于中国江苏省无锡市)的兼职首席财务官,以及瑞士资本亚洲(位于香港)的顾问。从2009年到2013年,Bennett先生担任位于中国北京的American General Business Association的首席执行官。2004年至2009年,他是北京Nexis投资咨询公司的合伙人。他是位于加利福尼亚的ProCFO公司的合伙人,该公司在2000-2004年期间为公司提供合同首席财务官服务。1998-2000年,他是夏威夷大学基本法、会计和税务教授,以及美国夏威夷檀香山查米纳德大学会计、税务和审计教授。此外,他曾担任南加州Argonaut Computers公司的首席财务官和董事会成员。他曾担任Chapman University的会计和审计教授,以及California State University at Fullerton的会计、税务和审计教授。他还曾担任the National Automobile Club的首席财务官和董事会成员。他毕业于密歇根州立大学(Michigan State University),获得金融工商管理硕士学位和会计学士学位。他从科罗拉多州获得了注册会计师执照,目前该执照已失效。


Gene Michael Bennett,has served as China Pharma Holdings, Inc. independent director since February 2008. Presently, Mr. Bennett is Chairman of the Board of Directors and Partner of Omana Healthcare, Ltd, Mission Viejo, California, USA, and Chairman and Partner of Prescient Crossborder Business Consulting, Ltd, Shenzhen, PRC. From 2013 through 2015 Mr. Bennett served as part-time CFO for Kang Jia Fu, Royal Traditional Health Investment Management Co. Ltd, located in Wuxi, Jiangsu Province, China and advisor to Swiss Capital Asia, located in Hong Kong. From 2009 through 2013, Mr. Bennett served as the CEO of American General Business Association, located in Beijing, China. Mr. Bennett was a partner of Nexis Investment Consulting Corporation based in Beijing from 2004-2009. He was a partner of ProCFO Company based in California which provided contract chief financial officer service for firms during 2000-2004. During 1998-2000, he was a basic law, accounting and tax professor at University of Hawaii, and an accounting, tax and audit professor at Chaminade University of Honolulu, Hawaii, USA. In addition, he previously served as the chief financial officer and member of the board of directors of Argonaut Computers in Southern California. Mr. Bennett worked as an accounting and audit professor at Chapman University and an accounting, tax, and audit professor at California State University at Fullerton. He also acted as chief financial officer and a board member of the National Automobile Club. Mr. Bennett graduated from Michigan State University with an MBA in Finance and BA in Accounting. He obtained his CPA license from the State of Colorado, which is currently inactive..
Gene Michael Bennett,自2008年2月起担任China Pharma Holdings, Inc.的独立董事。目前,Bennett先生是Omana Healthcare, Ltd (Mission Viejo, California, USA)的董事会主席和合伙人,以及Prescient Crossborder Business Consulting, Ltd (Shenzhen, PRC)的董事长和合伙人。从2013年到2015年,Bennett先生担任Kang Jia Fu, Royal Traditional Health Investment Management Co. Ltd(位于中国江苏省无锡市)的兼职首席财务官,以及瑞士资本亚洲(位于香港)的顾问。从2009年到2013年,Bennett先生担任位于中国北京的American General Business Association的首席执行官。2004年至2009年,他是北京Nexis投资咨询公司的合伙人。他是位于加利福尼亚的ProCFO公司的合伙人,该公司在2000-2004年期间为公司提供合同首席财务官服务。1998-2000年,他是夏威夷大学基本法、会计和税务教授,以及美国夏威夷檀香山查米纳德大学会计、税务和审计教授。此外,他曾担任南加州Argonaut Computers公司的首席财务官和董事会成员。他曾担任Chapman University的会计和审计教授,以及California State University at Fullerton的会计、税务和审计教授。他还曾担任the National Automobile Club的首席财务官和董事会成员。他毕业于密歇根州立大学(Michigan State University),获得金融工商管理硕士学位和会计学士学位。他从科罗拉多州获得了注册会计师执照,目前该执照已失效。
Gene Michael Bennett,has served as China Pharma Holdings, Inc. independent director since February 2008. Presently, Mr. Bennett is Chairman of the Board of Directors and Partner of Omana Healthcare, Ltd, Mission Viejo, California, USA, and Chairman and Partner of Prescient Crossborder Business Consulting, Ltd, Shenzhen, PRC. From 2013 through 2015 Mr. Bennett served as part-time CFO for Kang Jia Fu, Royal Traditional Health Investment Management Co. Ltd, located in Wuxi, Jiangsu Province, China and advisor to Swiss Capital Asia, located in Hong Kong. From 2009 through 2013, Mr. Bennett served as the CEO of American General Business Association, located in Beijing, China. Mr. Bennett was a partner of Nexis Investment Consulting Corporation based in Beijing from 2004-2009. He was a partner of ProCFO Company based in California which provided contract chief financial officer service for firms during 2000-2004. During 1998-2000, he was a basic law, accounting and tax professor at University of Hawaii, and an accounting, tax and audit professor at Chaminade University of Honolulu, Hawaii, USA. In addition, he previously served as the chief financial officer and member of the board of directors of Argonaut Computers in Southern California. Mr. Bennett worked as an accounting and audit professor at Chapman University and an accounting, tax, and audit professor at California State University at Fullerton. He also acted as chief financial officer and a board member of the National Automobile Club. Mr. Bennett graduated from Michigan State University with an MBA in Finance and BA in Accounting. He obtained his CPA license from the State of Colorado, which is currently inactive..
董宝文

董宝文,2008年2月任公司独立董事,2003年至2008年参加四川大学的专家团队,在工程设计和医疗科学师资队伍中教授评价和评估工作。近几年,他专注于中国医疗改革的研究。之前,他主要做生物医学研究和医学信息燕姐,在不同领域有不同角色,1974年至2001年,是四川大学的教导主任和教授。1966年至1974年,参与了通信技术领域的开发。1966年毕业于中国科学技术大学。他在科学和研究领域强大的学术背景为公司带来了研发方面的价值,成为工资的董事长。


Baowen Dong,has served as China Pharma Holdings, Inc. independent director since February 2008. Mr. Dong participated on the expert team of the Sichuan University from 2003 to 2008, doing teaching evaluation and assessment work in Engineering and Medical Science faculty. In the past few years, Mr. Dong has focused on the research of China's Health Care Reform. Previously, he concentrated on biomedical and medical information researches. Mr. Dong has had different roles in areas of teaching and research, including serving as a department head and a professor, at Sichuan University from 1974 to 2001. Additionally, Mr. Dong was engaged in the field of communication technology from 1966 to 1974. Mr. Dong graduated from Xidian University in 1966.
董宝文,2008年2月任公司独立董事,2003年至2008年参加四川大学的专家团队,在工程设计和医疗科学师资队伍中教授评价和评估工作。近几年,他专注于中国医疗改革的研究。之前,他主要做生物医学研究和医学信息燕姐,在不同领域有不同角色,1974年至2001年,是四川大学的教导主任和教授。1966年至1974年,参与了通信技术领域的开发。1966年毕业于中国科学技术大学。他在科学和研究领域强大的学术背景为公司带来了研发方面的价值,成为工资的董事长。
Baowen Dong,has served as China Pharma Holdings, Inc. independent director since February 2008. Mr. Dong participated on the expert team of the Sichuan University from 2003 to 2008, doing teaching evaluation and assessment work in Engineering and Medical Science faculty. In the past few years, Mr. Dong has focused on the research of China's Health Care Reform. Previously, he concentrated on biomedical and medical information researches. Mr. Dong has had different roles in areas of teaching and research, including serving as a department head and a professor, at Sichuan University from 1974 to 2001. Additionally, Mr. Dong was engaged in the field of communication technology from 1966 to 1974. Mr. Dong graduated from Xidian University in 1966.

高管简历

中英对照 |  中文 |  英文
李志林

李志林是公司的董事长、总裁、首席执行官和临时财务总监。她自2006年起担任董事,2005年任总裁和首席执行官,是惠普森的创立者,1993年至2005年是惠普森的董事长和首席执行官。以前是海口生物工程学院的校长和四川生物学院的副校长,毕业于四川大学,拥有生物学学位。


Zhilin Li,has served as a director since 2006 and as the President and Chief Executive Officer since 2005. She was a founder of Helpson, and served as Chairman and Chief Executive Officer of Helpson from 1993 to 2005. Ms. Li was formerly the president of Haikou Bio-Engineering Institute as well as the vice president of Sichuan Institute of Biology. She graduated from Sichuan University with a degree in biology.
李志林是公司的董事长、总裁、首席执行官和临时财务总监。她自2006年起担任董事,2005年任总裁和首席执行官,是惠普森的创立者,1993年至2005年是惠普森的董事长和首席执行官。以前是海口生物工程学院的校长和四川生物学院的副校长,毕业于四川大学,拥有生物学学位。
Zhilin Li,has served as a director since 2006 and as the President and Chief Executive Officer since 2005. She was a founder of Helpson, and served as Chairman and Chief Executive Officer of Helpson from 1993 to 2005. Ms. Li was formerly the president of Haikou Bio-Engineering Institute as well as the vice president of Sichuan Institute of Biology. She graduated from Sichuan University with a degree in biology.